You've never seen anything like it · Doors open inStarts at 7:00 PM ET
Skip to content

Research peptide · Immune research

KPV

A synthetic tripeptide, Lys-Pro-Val, corresponding to residues 11 to 13 at the C-terminus of alpha-melanocyte-stimulating hormone. At three residues and 342 g/mol it is one of the smallest peptides in this compendium.

Compound type
Research peptide
Research area
Immune
Formula
C16H30N4O4
Average mass
342.434 Da
Monoisotopic mass
342.2267 Da
Length
3 residues
PubChem
CID 125672

What it is

KPV is a synthetic tripeptide of lysine, proline and valine in that order. Its molecular formula is C16H30N4O4 and its average molecular weight is 342.43 g/mol. It carries CAS number 67727-97-3 and PubChem CID 125672, and is indexed under alpha-MSH(11-13), ACTH(11-13), MSH(11-13) and the systematic name L-lysyl-L-prolyl-L-valine.

The sequence is a fragment rather than a designed molecule. Lys-Pro-Val occupies positions 11 to 13, the C-terminal end, of alpha-melanocyte-stimulating hormone, a 13-residue peptide hormone that is itself a proteolytic product of proopiomelanocortin. The same three residues therefore also correspond to positions 11 to 13 of ACTH, which shares those residues with alpha-MSH, and its aliases reflect both derivations.

Discovery and origin

KPV entered the literature through fragment work on alpha-MSH, in which the parent hormone was divided into subsequences to determine which part of the chain accounted for which measured activity in assay systems. The C-terminal tripeptide was identified as the minimal fragment retaining measurable activity in several of those assays, and has been studied under the alpha-MSH(11-13) designation ever since. At three residues it is synthesized rather than isolated.

Structure and chemistry

At three residues, KPV sits at the boundary between peptide and small-molecule chemistry and behaves in most practical respects like the latter. It is freely soluble in water and in aqueous buffer, highly polar, and zwitterionic at neutral pH: the lysine side-chain amine and the free N-terminal amine are protonated and the C-terminal carboxylate is deprotonated, giving a net positive charge of roughly one.

Two structural features are worth noting. The central proline constrains the backbone and introduces cis and trans amide isomers about the Lys-Pro bond, which can appear in NMR spectra as doubled resonances and occasionally as peak broadening in chromatography. The valine carboxylate at the C-terminus is free rather than amidated, which matters when comparing material against literature preparations, since amidated analogs of short MSH fragments also exist.

The sequence contains no aromatic residue, no cysteine and no methionine, so there is no disulfide chemistry and only weak ultraviolet absorbance above 220 nm. The lack of a chromophore is the main analytical inconvenience.

How it is studied in the laboratory

The most frequently cited laboratory study of KPV is a 2008 report combining cell-culture and rodent work. The cell systems were the intestinal epithelial lines Caco2-BBE and HT29-Cl.19A and the Jurkat T-cell line, stimulated with pro-inflammatory cytokines in the presence or absence of the tripeptide; readouts spanned an NF-kappaB luciferase reporter construct, Western blot, real-time RT-PCR and ELISA, so the endpoints were reporter activity, protein levels and cytokine secretion rather than any organism-level outcome 1.

The same study addressed transport directly. Uptake experiments used unlabeled KPV as a competitor against a radiolabeled substrate of the di- and tripeptide transporter PepT1, and tritiated KPV to establish uptake kinetics; this is the work underlying the description of KPV as a PepT1 substrate, and the authors reported that it acts via PepT1 expressed in both intestinal epithelial and immune cell lines, at nanomolar concentrations in the cell assays 1.

The animal component used two standard rodent colitis models, DSS-induced and TNBS-induced colitis in mice, with the tripeptide supplied in drinking water and inflammation assessed histologically and by cytokine mRNA expression; the paper reported a reduced incidence of colitis in both models alongside decreased cytokine expression 1. Beyond this paper the non-human literature on the isolated tripeptide is thin.

Analytical notes

Identity is confirmed by liquid chromatography coupled to mass spectrometry in positive ion mode. On the average mass of 342.43 g/mol, the expected singly protonated ion falls near m/z 343.44; a monoisotopic calculation on 342.23 places [M+H]+ near 343.23 instead, and at this mass the gap between conventions is large relative to the usual tolerance, so the certificate should state which it uses. Its fragmentation is also simple enough that the b and y ion series confirm residue order outright.

Purity is assessed by reversed-phase HPLC, but with no chromophore the detection wavelength drops to about 214 nm or below, and a very polar tripeptide is weakly retained on standard C18 columns. Ion-pairing with trifluoroacetic acid, an aqueous-compatible stationary phase, or HILIC are the usual answers, and charged-aerosol or evaporative light-scattering detection is an alternative where ultraviolet detection is too insensitive. The impurities worth resolving are the fragments KP and PV, free amino acids, and diastereomers from epimerization; the cis and trans proline isomers should not be mistaken for an impurity peak.

Storage and handling in the laboratory

As supplied, the material is a lyophilized white powder, soluble in water and in aqueous buffer, stored at -20 degrees Celsius and protected from light. Short, highly polar peptides of this kind are relatively robust in the dry state, and the main handling concern is moisture uptake by the hygroscopic lysine-containing salt form, so vials should reach room temperature before opening. Counter-ion content, usually acetate or trifluoroacetate, is proportionally more significant for a 342 g/mol peptide than for a large one, so gravimetric standards should account for the salt.

Open questions in the literature

The receptor-level question is unresolved: the cited work establishes PepT1-mediated uptake into cells, but transport is not the same as a molecular target, and what the tripeptide binds once inside the cell is not settled 1. Whether the activity measured in the two mouse colitis models and the cultured lines generalizes to other model systems has not been tested broadly. Basic physicochemical characterization is also sparse: the stability of the tripeptide in culture media, and the distribution of its cis and trans proline isomers under assay conditions, are not well documented.

Identity check

A mass-spectrometry result for KPV should show peaks near these values. A result more than about one unit away is worth a question to the testing lab. Salt forms such as acetate or TFA do not move these peaks, though they do mean less peptide in each milligram of powder.

IonExpected m/z
[M+H]+343.23

References

  1. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. doi:10.1053/j.gastro.2007.10.026. Source

For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.